Mark G Erlander

Mark G Erlander

UNVERIFIED PROFILE

Are you Mark G Erlander?   Register this Author

Register author
Mark G Erlander

Mark G Erlander

Publications by authors named "Mark G Erlander"

Are you Mark G Erlander?   Register this Author

45Publications

1102Reads

17Profile Views

Longitudinal monitoring of ctDNA EGFR mutation burden from urine correlates with patient response to EGFR TKIs: A case series.

Lung Cancer 2017 06 20;108:22-28. Epub 2017 Feb 20.

Beverly Hills Cancer Center, 8900 Wilshire Blvd, Beverly Hills, CA 90211, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.02.010DOI Listing
June 2017

Prospective blinded study of BRAFV600E mutation detection in cell-free DNA of patients with systemic histiocytic disorders.

Cancer Discov 2015 Jan 16;5(1):64-71. Epub 2014 Oct 16.

Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-14-0742DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705028PMC
January 2015

Cost effectiveness of a 92-gene assay for the diagnosis of metastatic cancer.

J Med Econ 2014 Aug 14;17(8):527-37. Epub 2014 May 14.

Partnership for Health Analytic Research LLC , Beverly Hills, CA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3111/13696998.2014.909817DOI Listing
August 2014

Health economic analysis of Breast Cancer Index in patients with ER+, LN- breast cancer.

Am J Manag Care 2014 Aug 1;20(8):e302-10. Epub 2014 Aug 1.

Health Advances, LLC, 9 Riverside Rd, Weston, MA 02493. E-mail:

View Article

Download full-text PDF

Source
August 2014

A 92-gene cancer classifier predicts the site of origin for neuroendocrine tumors.

Mod Pathol 2014 Jan 12;27(1):44-54. Epub 2013 Jul 12.

Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2013.105DOI Listing
January 2014

Development and validation of a 32-gene prognostic index for prostate cancer progression.

Proc Natl Acad Sci U S A 2013 Apr 26;110(15):6121-6. Epub 2013 Mar 26.

Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1215870110DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625257PMC
April 2013

Gene expression-based diagnostics for molecular cancer classification of difficult to diagnose tumors.

Expert Opin Med Diagn 2012 Sep 10;6(5):407-19. Epub 2012 Jul 10.

BioTheranostics, Inc., San Diego, CA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/17530059.2012.704363DOI Listing
September 2012

Multisite validation study to determine performance characteristics of a 92-gene molecular cancer classifier.

Clin Cancer Res 2012 Jul 30;18(14):3952-60. Epub 2012 May 30.

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-0920DOI Listing
July 2012

Prognostic utility of the breast cancer index and comparison to Adjuvant! Online in a clinical case series of early breast cancer.

Breast Cancer Res 2011 Oct 14;13(5):R98. Epub 2011 Oct 14.

Department of Medicine, Division of Hematology/Oncology, UPMC, University of Pittsburgh Cancer Institute, 300 Halket Street, Suite 4628, Pittsburgh, PA 15213, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr3038DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262211PMC
October 2011

Molecular classification of cancers of unknown primary site.

Mol Diagn Ther 2009 Dec;13(6):367-73

Sarah Cannon Cancer Center, Nashville, Tennessee 37203, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/bf03256342DOI Listing
December 2009

Molecular classification of unknown primary cancer.

Semin Oncol 2009 Feb;36(1):38-43

Agendia, Inc, Huntington Beach, CA 92647, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S009377540800215
Publisher Site
http://dx.doi.org/10.1053/j.seminoncol.2008.10.002DOI Listing
February 2009

Laser capture microdissection and advanced molecular analysis of human breast cancer.

J Mammary Gland Biol Neoplasia 2003 Jul;8(3):335-45

Department of Pathology, Harvard Medical School, Molecular Pathology Research Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1023/b:jomg.0000010033.49464.0cDOI Listing
July 2003

Global gene expression analysis of single cells.

Curr Opin Drug Discov Devel 2003 Mar;6(2):231-6

Johnson & Johnson Pharmaceutical R&D LLC, San Diego, CA 92121, USA.

View Article

Download full-text PDF

Source
March 2003

Laser capture microdissection and its applications in genomics and proteomics.

Methods Enzymol 2002 ;356:12-25

Hormone Receptor Laboratory, James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky 40202, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0076-6879(02)56919-6DOI Listing
December 2002